Anti-MIP-1 alpha/CCL3 + CCL3L1 antibody [EPR22529-19],Abcam,AB229900

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Human, Mouse

Application

WB, ICC/IF, IP, Flow Cyt (Intra)

Platform ID

BAB260596676

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-MIP-1 alpha/CCL3 + CCL3L1 antibody [EPR22529-19]
Cat. No.AB229900
HostRabbit
IsotypeIgG
ReactivityHuman, Mouse
ApplicationWB, ICC/IF, IP, Flow Cyt (Intra)
ClonalityMonoclonal
Clone NumberEPR22529-19
Concentration0.551 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Monokine with inflammatory and chemokinetic properties. Binds to CCR1, CCR4 and CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-alpha induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). See full target information CCL3 Additional targets CCL3L1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.